Onychomycosis in Children: an overview
February 2003 | Volume 2 | Issue 1 | Original Article | 31 | Copyright © February 2003
Aditya K. Gupta, MD, PhD, FRCP(C) and Robert Baran, MD
Abstract
Onychomycosis in children is relatively uncommon, with a prevalence of approximately 0.3% worldwide. The most common
etiologic organism is Trichophyton rubrum. The oral antifungal agents terbinafine, itraconazole, and fluconazole, and
the topical nail lacquers ciclopirox and amorolfine, are not approved for use in treating onychomycosis in children.
However, these agents appear to be effective and safe in this indication. 
